FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Ascend Laboratories Amlodipine Besylate Tablet Recall

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Al…

Ascend Laboratories LLC · Montvale, NJ

Risk level
Class III
Reported by FDA
Sep 20, 2017
Recall ID
D-1134-2017
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Amlodipine Besylate Tablet starting May 5, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1134-2017 on Sep 20, 2017. Reason: PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg. Status: Terminated.

Why it was recalled

PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Product description

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

Lot numbers, UPCs & expiration codes

Lot #: 6142626, Exp 09/19

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1134-2017
Classification
Class III
Status
Terminated
Recall initiated
May 5, 2017
FDA report date
Sep 20, 2017
Quantity
1212 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-1134-2017, exactly as published.

Show all FDA fields
City
Montvale
State
NJ
Status
Terminated
Country
United States
Event ID
77948
Address
180 Summit Ave Ste 200
Code information
Lot #: 6142626, Exp 09/19
Postal code
07645-1722
Report date
Sep 20, 2017
Product type
Drugs
Recall number
D-1134-2017
Classification
Class III
Recalling firm
Ascend Laboratories LLC
Product quantity
1212 bottles
Termination date
Apr 25, 2018
Reason for recall
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10
Distribution pattern
Nationwide in the USA.
Recall initiation date
May 5, 2017
Initial firm notification
Letter
Center classification date
Sep 11, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1134-2017, published Sep 20, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls